A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...
In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now locked in another big biotech deal.
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
The U.S. Department of Labor alleged wrongful denials for ER and urinary drug screening; Eden Prairie-based company says processes are no longer in place.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback